COZZI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.341
AS - Asia 2.611
EU - Europa 2.160
SA - Sud America 601
AF - Africa 545
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 35
Totale 14.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.025
SG - Singapore 919
CN - Cina 569
HK - Hong Kong 426
BR - Brasile 408
IT - Italia 393
DE - Germania 285
FI - Finlandia 259
SE - Svezia 143
PL - Polonia 134
UA - Ucraina 123
FR - Francia 114
VN - Vietnam 99
RU - Federazione Russa 93
GB - Regno Unito 69
IN - India 68
NL - Olanda 50
IE - Irlanda 47
AR - Argentina 36
CA - Canada 34
TR - Turchia 34
EC - Ecuador 30
GR - Grecia 30
AT - Austria 26
MX - Messico 26
IQ - Iraq 25
AE - Emirati Arabi Uniti 24
ZA - Sudafrica 24
CZ - Repubblica Ceca 23
BE - Belgio 22
CO - Colombia 22
JM - Giamaica 22
JP - Giappone 22
NI - Nicaragua 22
PK - Pakistan 22
VE - Venezuela 22
ES - Italia 21
IL - Israele 21
KZ - Kazakistan 21
PT - Portogallo 21
AZ - Azerbaigian 20
BG - Bulgaria 20
ID - Indonesia 20
IR - Iran 20
KH - Cambogia 20
PA - Panama 20
SO - Somalia 20
BY - Bielorussia 19
CM - Camerun 19
EG - Egitto 19
AL - Albania 18
GF - Guiana Francese 18
NE - Niger 18
SN - Senegal 18
UG - Uganda 18
CW - ???statistics.table.value.countryCode.CW??? 17
DK - Danimarca 17
GT - Guatemala 17
MY - Malesia 17
PS - Palestinian Territory 17
RO - Romania 17
TN - Tunisia 17
UZ - Uzbekistan 17
XK - ???statistics.table.value.countryCode.XK??? 17
CI - Costa d'Avorio 16
EE - Estonia 16
GA - Gabon 16
GN - Guinea 16
JO - Giordania 16
MK - Macedonia 16
PR - Porto Rico 16
RS - Serbia 16
SI - Slovenia 16
SK - Slovacchia (Repubblica Slovacca) 16
TJ - Tagikistan 16
AM - Armenia 15
BJ - Benin 15
CG - Congo 15
CU - Cuba 15
DZ - Algeria 15
HN - Honduras 15
KG - Kirghizistan 15
MA - Marocco 15
MG - Madagascar 15
PY - Paraguay 15
AO - Angola 14
BS - Bahamas 14
CR - Costa Rica 14
CV - Capo Verde 14
DO - Repubblica Dominicana 14
KE - Kenya 14
LV - Lettonia 14
MD - Moldavia 14
SA - Arabia Saudita 14
UY - Uruguay 14
BO - Bolivia 13
BZ - Belize 13
KR - Corea 13
LU - Lussemburgo 13
LY - Libia 13
Totale 13.745
Salva come PNG Salva come JPEG
Città #
Fairfield 963
Chandler 722
Woodbridge 611
Ann Arbor 609
Houston 588
Ashburn 579
Singapore 560
Jacksonville 479
Hong Kong 410
Wilmington 406
Cambridge 318
Seattle 316
Santa Clara 233
Princeton 230
Boardman 223
Des Moines 158
Beijing 118
San Diego 117
Bytom 110
Nanjing 106
Medford 104
Helsinki 96
Roxbury 65
Munich 52
Los Angeles 50
Dublin 43
Padova 38
São Paulo 33
Guangzhou 29
Hebei 29
Nanchang 25
Ho Chi Minh City 23
Jiaxing 22
Managua 22
Chennai 21
Shenyang 21
Baku 20
Hefei 19
Phnom Penh 19
Tianjin 19
Dakar 18
Hanoi 18
Kampala 18
Milan 18
New York 18
Panama City 18
Athens 17
Tashkent 17
Vienna 17
Abidjan 16
Amman 16
Changsha 16
Conakry 16
Dong Ket 16
Libreville 16
Boston 15
Buffalo 15
Chicago 15
Council Bluffs 15
Kingston 15
London 15
Norwalk 15
Antananarivo 14
Cayenne 14
Dushanbe 14
Luanda 14
Nassau 14
Niamey 14
Rio de Janeiro 14
Turin 14
Yerevan 14
Nairobi 13
Turku 13
Yaoundé 13
Abu Dhabi 12
Castries 12
Cotonou 12
Dallas 12
Hargeisa 12
Montevideo 12
Naples 12
Nouakchott 12
Noumea 12
Praia 12
Pristina 12
San Francisco 12
Tallinn 12
Ulan Bator 12
Willemstad 12
Almaty 11
Andorra la Vella 11
Bishkek 11
Brazzaville 11
Bridgetown 11
Curitiba 11
Havana 11
Minsk 11
Nuremberg 11
Quito 11
Riga 11
Totale 9.432
Salva come PNG Salva come JPEG
Nome #
Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti. 225
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 196
Therapy of scleroderma renal crisis: State of the art 179
Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients 171
High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis 161
Effects of mud-bath therapy in psoriatic arthritis patients treated with TNF inhibitors. Clinical evaluation and assessment of synovial inflammation by contrast-enhanced ultrasound (CEUS). 159
Prognosis of scleroderma renal crisis: a long-term observational study. 155
Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area 155
Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study 148
Right heart function by 3D-echocardiography and 2D-speckle tracking in scleroderma patients in absence of pulmonary hypertension 147
Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review 146
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 144
Adult Henoch-Schonlein purpura with glomerulonephritis and paroxysmal nocturnal haemoglobinuria: an uncommon association 143
Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis. 142
Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? 142
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 142
Effets du traitement par les bains de boue dans le rhumatisme psoriasique chez les patients traités par anti-TNF. Évaluation clinique et par échographie de contraste de l'inflammation synoviale 141
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. 137
Right ventricular function by 3D-echocardiography and 2D-speckle tracking in scleroderma patients in absence of pulmonary hypertension 135
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 135
[Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases] 133
The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors. 132
Causes and risk factors for death in systemic sclerosis. A study from the EULAR Scleroderma Trials And Research (EUSTAR) data base. 129
Plasma-exchange as a "rescue therapy" for dermato/polymyositis in acute phase. Experience in three young patients 128
How I treat patients with systemic sclerosis in clinical practice 127
Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study. 126
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group 125
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 124
Short-term effects of plasma exchange on coagulation factors in a sclerodermic patient. 123
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature. 123
The power of the EUSTAR cohort: key findings to date and implicationsfor management of systemic sclerosis patients 121
PD-1 gene rs2227981 (PD-1.5) polymorphism analysis in patients with systemic sclerosis 121
Prevalenza e significato clinico degli anticorpi anti-catepsina G nella sclerosi sistemica. 120
Clinical manifestations and outcome of polyarthralgia associated with chronic lymphocytic thyroiditis 117
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study. 116
Effect of Bosentan on Plasma Markers of Endothelial Cell Activity in Patients with Secondary Pulmonary Hypertension Related to Connective Tissue Diseases. 114
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction 113
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 113
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 112
Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients 111
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. 111
The social costs of digital ulcer management in sclerodema patients: An observational Italian pilot study 110
Mud-bath treatment in spondylitis associated with inflammatory bowel disease - a pilot randomised clinical trial. 110
Antifibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts. 109
Lacrimal defects in adult and senile rheumatoid arthritis. 108
Anti-inflammatory effect of mud-bath applications on adjuvant arthritis in rats 107
Neuroendocrine effects of a cycle of fangotherapy 107
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients. 105
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: A 10-year longitudinal study from the EUSTAR database 105
Long-term improvement in activities of daily living in women with systemic sclerosis attending to occupational therapy. 104
Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis 103
Aprroccio Riabilitativo alla sclerodermia. 103
La terapia dell'artrite reumatoide mediante levamisolo. 100
Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produceprofibrotic chemokines, with partial exploitation of toll-like receptor 4. 100
Systemic sclerosis in a patient with recent nasopharyngeal carcinoma: an unusual combination. 98
[Digital ulcers in a cohort of 333 scleroderma patients] 97
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 97
Right ventricular mechanics changes according to pressure overload increasing, a 2D-speckle tracking echocardiographic evaluation 97
Hypothalamic-pituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. 96
Effects of mud-bath applications on synovial inflammation evaluated by contrasted-enhanced ultrasound (CEUS) in patients with psoriatic arthritis 95
Unstabilized DNA breaks in lymphocytes of patients with different subsets of systemic sclerosis 94
BONE EFFECTS OF MUD-BATH THERAPY IN THE EUGANEAN AREA. A DENSITOMETRIC AND METABOLIC STUDY 94
Pentraxins, anti-pentraxins antibodies and atherosclerosis 93
Left atrial remodeling and dysfunction occur early in patients with systemic sclerosis and normal left ventricular function 91
Long-term therapy with plasma-exchange in systemic sclerosis: effects on laboratory markers reflecting the disease activity 90
Mortality and morbility in Italian patients with Sjögren syndrome. 88
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 88
Left ventricular subclinical dysfunction by 2D-speckle tracking in systemic sclerosis patients according to autoantibody pattern 88
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 88
CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis. 87
Trattamento con innesti di tessuto adiposo della fibrosi cutanea periorale in pazienti affette da sclerosi sistemica progressiva 87
Bosentan may induce arthritis flare in sclerodermia patients concomitantly treated with methotrexate. 87
Digital ulcers predict a worse disease course in patients with systemic sclerosis 87
Capillary Blood Volume Measurement In Scleroderma Patients Submitted To Nitric Oxide Diffusion Test 86
Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial 85
NITRIC OXIDE DIFFUSION IN PATIENTS WITH SSc 84
Gli autoanticorpi antitissutali durante la terapia con levamisolo nell'artrite reumatoide. 83
Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not inSjogren's Syndrome, Salivary Glands. 81
Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: Dual-1 and Dual-2 randomized clinical trials 81
Prevalenza e caratteristiche cliniche della fibromialgia nelle connettiviti maggiori: lupus eritematoso sistemico, sclerosi sistemica e sindrome di Sjögren primitiva. 78
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. 78
Mixed connective tissue disease (MCTD): one diagnosis, more evolutions. 78
Heparin, cartopril and dermatansulphate are ineffective in preventing bleomycin-induced lung fibrosis in rats. 78
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. 78
Incidence of subclinical myocardial dysfunction in patients with systemic sclerosis and normal left ventricular systolic and diastolic function. 78
Unstabilized DNA breaks in lymphocytes of patients with systemic sclerosis. 77
Causes of death in systemic sclerosis – A report from the EUSTAR data base. 77
Sclerodermia 76
Brief Report: Successful pregnancies but a higher riskof preterm births in patients with systemic sclerosis: An Italian multicenterstudy 76
Serologic profile and mortality rates of scleroderma renal crisis in Italy. 74
Prevalence and clinical significance of cathepsin G antibodies in systemic sclerosis. 74
Higher Ventricular-Arterial Coupling Derived from Three-Dimensional Echocardiography Is Associated with a Worse Clinical Outcome in Systemic Sclerosis 73
Levels of neuropeptides in bronchoalveolar lavage (BAL) fluids of patients with systemic sclerosis. 73
Exerxise-induced arterial pulmonary hypertension in systemic sclerosis: an echocardiography study. 73
Autoantibodies to Bactericidal/Permeability-Increasing Protein and Cathepsin G in Systemic Sclerosis 72
Efficacy of mud-bath treatment in spondylitis associated with inflammatory bowel disease. 72
Autoantibody profile of scleroderma renal crisis in Italy. 72
Induced sputum : a non-invasive tool for evaluation of lung involvement and alveolar inflammation in systemic sclerosis. 71
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases.] 71
Socioeconomic costs of digital ulcer treatment among patients with systemic sclerosis: A pilot observational study in Italy 71
Totale 10.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.370
article - articoli 43.619
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.259
Totale 93.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021955 0 0 24 97 45 93 16 122 167 84 144 163
2021/20221.581 31 276 135 131 52 103 68 156 67 31 145 386
2022/20231.533 319 136 30 171 253 279 4 104 172 13 44 8
2023/2024598 31 95 53 45 41 47 18 25 53 39 72 79
2024/20252.922 4 267 130 164 390 91 108 301 254 89 445 679
2025/20262.806 401 1.107 1.298 0 0 0 0 0 0 0 0 0
Totale 14.439